Navigation Links
Hip Osteoarthritis Therapy No Better Than Placebo
Date:3/6/2009

FDA-approved injection for knees less effective in deep joint areas, study finds

FRIDAY, March 6 (HealthDay News) -- A single injection of hyaluronic acid is no more effective than a placebo in treating hip osteoarthritis (OA), a new French study finds.

Hyaluronic acid (HA), a substance found in normal joint fluid, is used to restore the elasticity of synovial fluid, which lubricates and protects joints. The use of HA injections to treat knee OA is approved by the U.S. Food and Drug Administration, but there's little evidence to support its use in treating hip OA.

This study included 85 patients with hip OA who were randomly selected to receive either a single injection of HA or a placebo. When the patients were assessed for pain, stiffness and disability three months later, the researchers found no difference between HA and placebo.

The study was published in the March issue of Arthritis & Rheumatism.

"The absence of any difference between treatment arms likely reflects the lack of clinical effect of one single intra-articular injection of HA for hip OA," wrote the researchers at the Henri-Mondor Hospital in Paris. The findings are similar to a recent review of other trials of HA injection in patients with hip OA.

A single injection of HA may not have much effect on knee OA, because it may be rapidly cleared from the synovial fluid compartment, the French team said.

"Future studies are warranted to confirm our results and to evaluate the effects of repeated HA injections in hip OA," they concluded.

More information

The American Academy of Orthopaedic Surgeons has more about hip osteoarthritis.



-- Robert Preidt



SOURCE: Wiley-Blackwell, news release, March 3, 2009
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis
3. New insights into inflammation in osteoarthritis
4. Study shows pine bark naturally reduces osteoarthritis knee pain
5. Orthopedic Surgeon Contributes Knowledge on Research and Treatment in Weekly Blogs on MyOsteoarthritisCentral.com
6. The risk of osteoarthritis and index to ring finger length ratio
7. Genes Linked to Height Also Tied to Osteoarthritis Risk
8. Gender Bias at Play in Treatment of Knee Osteoarthritis
9. Gender bias may affect care of people with osteoarthritis, study finds
10. Study Shows Pine Bark Naturally Reduces Osteoarthritis
11. Study shows pine bark naturally reduces osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hip Osteoarthritis Therapy  No Better Than Placebo
Hip Osteoarthritis Therapy No Better Than Placebo
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 1Baxa Corporation Releases IntelliFlowRx 28TM 29 Upgrades 49198 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 1Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late Stage Leukaemia 12671 7Stroke Damage Is Less in Rats Given Opioids 49194 1